TCL Archive NCI Promises Strong Monitoring Process Visco Calls For Independent Review; Rep. Dingell Plans Hearing April 13 April 1, 1994
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive NCI Gets Long List Of Consortium Center Needs, Including New Guidelines, Review, More “Glue” September 14, 1984
TCL Archive Consensus Conference agrees That Nevi Can Be Precursors For Melanoma, Offers Management Suggestions November 4, 1983